Nalaganje...
Clinical potential of aclidinium bromide in chronic obstructive pulmonary disease
Three long-acting muscarinic antagonists (LAMAs) are now available in Europe, providing clinicians and patients with a choice of interventions, which is important in COPD, which is clinically a heterogeneous disease. The first LAMA, tiotropium, has been widely used over the last decade as a once-dai...
Shranjeno v:
| izdano v: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4381904/ https://ncbi.nlm.nih.gov/pubmed/25848244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S76520 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|